Literature DB >> 10751853

Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.

T C Chai1, C O Zhang, J L Shoenfelt, H W Johnson, J W Warren, S Keay.   

Abstract

PURPOSE: The etiology of interstitial cystitis is unknown. Urine from patients with interstitial cystitis has been shown to inhibit urothelial proliferation through a putative antiproliferative factor and to contain decreased levels of heparin-binding epidermal growth factor-like growth factor (HB-EGF) compared to controls. Stretch of detrusor smooth muscle cells is known to stimulate HB-EGF production. Because bladder hydrodistention sometimes alleviates the symptoms of interstitial cystitis, we determined whether the stretch stimulus of hydrodistention alters antiproliferative factor activity and/or HB-EGF in interstitial cystitis urine specimens.
MATERIALS AND METHODS: Urine was collected immediately before, and 2 to 4 hours and 2 weeks after hydrodistention from 15 patients with symptoms and cystoscopic findings compatible with interstitial cystitis and 13 controls. Hydrodistention was performed with the subject under general or regional anesthesia and bladders were distended to 80 cm. water 3 times. Urinary HB-EGF was measured by enzyme-linked immunosorbent assay and urinary antiproliferative factor activity was determined by measuring 3H-thymidine uptake by normal human bladder urothelial cells.
RESULTS: Hydrodistention significantly increased urinary HB-EGF in patients with interstitial cystitis toward normal control values (before distention p = 0.003, 2 weeks after distention p = 0.67). Urine antiproliferative factor activity decreased significantly after hydrodistention in patients with interstitial cystitis. However, antiproliferative factor activity in interstitial cystitis and control specimens was still statistically different 2 weeks after distention (before distention p = 0.0000004, 2 weeks after distention p = 0.04).
CONCLUSIONS: Bladder stretch increased HB-EGF and conversely reduced antiproliferative factor activity in urine from patients with interstitial cystitis but not controls up to 2 weeks after distention. These results provide additional evidence for the possible role of antiproliferative factor and decreased HB-EGF in the pathophysiology of interstitial cystitis. To our knowledge this is also the first human study to show that in vivo bladder stretch can alter urinary factors that regulate cell growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751853

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Effective combination of hydrostatic pressure and aligned nanofibrous scaffolds on human bladder smooth muscle cells: implication for bladder tissue engineering.

Authors:  Hana Hanaee Ahvaz; Masoud Soleimani; Hamid Mobasheri; Behnaz Bakhshandeh; Naser Shakhssalim; Sara Soudi; Maryam Hafizi; Mohammad Vasei; Masumeh Dodel
Journal:  J Mater Sci Mater Med       Date:  2012-06-07       Impact factor: 3.896

2.  Evaluation of several botulinum toxins-A delivering systems into the bladder in interstitial cystitis/painful bladder syndrome (IC/PBS).

Authors:  Farbod Torkamand; Seyed Javad Mirjavadi; Fatemeh Khatami; Fateme Guitynavard; Seyed Mohammad Kazem Aghamir
Journal:  Am J Clin Exp Urol       Date:  2019-10-25

3.  Changes in urine markers and symptoms after bladder distention for interstitial cystitis.

Authors:  Deborah R Erickson; Allen R Kunselman; Christina M Bentley; Kenneth M Peters; Eric S Rovner; Laurence M Demers; Marcia A Wheeler; Susan K Keay
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

4.  Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.

Authors:  Anthony T Corcoran; Naoki Yoshimura; Vikas Tyagi; Bruce Jacobs; Wendy Leng; Pradeep Tyagi
Journal:  World J Urol       Date:  2012-03-24       Impact factor: 4.226

Review 5.  Cystitis, co-morbid disorders and associated epithelial dysfunction.

Authors:  Lori A Birder; Ann T Hanna-Mitchell; Emeran Mayer; Charles A Buffington
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

6.  Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation.

Authors:  Jayoung Kim; Susan K Keay; Michael R Freeman
Journal:  BJU Int       Date:  2008-10-16       Impact factor: 5.588

7.  Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).

Authors:  Susan Keay; Jay E Reeder; Kristopher Koch; Chen-Ou Zhang; Daivd Grkovic; Kenneth Peters; Yawei Zhang; John W Kusek; Lee M Nyberg; Christopher K Payne; Kathleen J Propert
Journal:  World J Urol       Date:  2007-08-13       Impact factor: 4.226

8.  A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2.

Authors:  Jayoung Kim; Susan K Keay; Sungyong You; Massimo Loda; Michael R Freeman
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

Review 9.  Urinary and Serologic Markers forInterstitial Cystitis: An Update.

Authors:  David R Wilkinson; And Deborah R Erickson
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

Review 10.  Lower urinary tract physiology and pharmacology.

Authors:  M E DiSanto; A J Wein; S Chacko
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.